Somatic mutations in BCOR have been reported in hematological malignancies, including acute myeloid leukemia and myelodysplastic syndromes51–53, and has also been reported at a low prevalence in other cancers, including lung, endometrial, breast and colon cancers54. This evidence concerns the gene BCOR and hematologic disorder.